Prukova, D, et al. (2019) Co-targeting of BCL2 with venetoclax and MCL1 with S63845 is synthetically lethal in vivo in relapsed mantle cell lymphoma. Clin. Cancer Res.. 2019 Apr 19;. PM ID: 31004002